{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:52Z","timestamp":1794330352663,"version":"4.9.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cancer is often called a disease of aging. There are numerous ways in which cancer epidemiology and behaviour change with the age of the patient. The molecular bases for these relationships remain largely underexplored. To characterise them, we analyse age-associations in the nuclear and mitochondrial somatic mutational landscape of 20,033 tumours across 35 tumour-types. Age influences both the number of mutations in a tumour (0.077 mutations per megabase per year) and their evolutionary timing. Specific mutational signatures are associated with age, reflecting differences in exogenous and endogenous oncogenic processes such as a greater influence of tobacco use in the tumours of younger patients, but higher activity of DNA damage repair signatures in those of older patients. We find that known cancer driver genes such as\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    and\n                    <jats:italic>CREBBP<\/jats:italic>\n                    are mutated in age-associated frequencies, and these alter the transcriptome and predict for clinical outcomes. These effects are most striking in brain cancers where alterations like\n                    <jats:italic>SUFU<\/jats:italic>\n                    loss and\n                    <jats:italic>ATRX<\/jats:italic>\n                    mutation are age-dependent prognostic biomarkers. Using three cancer datasets, we show that age shapes the somatic mutational landscape of cancer, with clinical implications.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-27889-y","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T06:02:51Z","timestamp":1641880971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Age influences on the molecular presentation of tumours"],"prefix":"10.1038","volume":"13","author":[{"given":"Constance H.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6685-5480","authenticated-orcid":false,"given":"Syed","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-7520","authenticated-orcid":false,"given":"Paul C.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"27889_CR1","doi-asserted-by":"crossref","unstructured":"Cook, M. B. et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 18, 1174\u20131182 (2009).","DOI":"10.1158\/1055-9965.EPI-08-1118"},{"key":"27889_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","volume":"27","author":"G Edgren","year":"2012","unstructured":"Edgren, G., Liang, L., Adami, H.-O. & Chang, E. T. Enigmatic sex disparities in cancer incidence. Eur. J. Epidemiol. 27, 187\u2013196 (2012).","journal-title":"Eur. J. Epidemiol."},{"key":"27889_CR3","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(00)02261-3","volume":"355","author":"H Elsaleh","year":"2000","unstructured":"Elsaleh, H. et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet Lond. Engl. 355, 1745\u20131750 (2000).","journal-title":"Lancet Lond. Engl."},{"key":"27889_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","volume":"20","author":"MB Cook","year":"2011","unstructured":"Cook, M. B., McGlynn, K. A., Devesa, S. S., Freedman, N. D. & Anderson, W. F. Sex Disparities in Cancer Mortality and Survival. Cancer Epidemiol. Biomark. Prev. 20, 1629\u20131637 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"27889_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.euf.2017.01.006","volume":"4","author":"G Scelo","year":"2018","unstructured":"Scelo, G., Li, P., Chanudet, E. & Muller, D. C. Variability of Sex Disparities in Cancer Incidence over 30 Years: The Striking Case of Kidney Cancer. Eur. Urol. Focus 4, 586\u2013590 (2018).","journal-title":"Eur. Urol. Focus"},{"key":"27889_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5902-z","volume":"19","author":"D Zheng","year":"2019","unstructured":"Zheng, D. et al. Sexual dimorphism in the incidence of human cancers. BMC Cancer 19, 684 (2019).","journal-title":"BMC Cancer"},{"key":"27889_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cam4.1277","volume":"7","author":"R Nipp","year":"2018","unstructured":"Nipp, R. et al. Disparities in cancer outcomes across age, sex, and race\/ethnicity among patients with pancreatic cancer. Cancer Med. 7, 525\u2013535 (2018).","journal-title":"Cancer Med."},{"key":"27889_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13091-y","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang, W., Edwards, A., Flemington, E. K. & Zhang, K. Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate. Sci. Rep. 7, 13639 (2017).","journal-title":"Sci. Rep."},{"key":"27889_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. Ca. Cancer J. Clin. 70, 7\u201330 (2020).","journal-title":"Ca. Cancer J. Clin."},{"key":"27889_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3322\/caac.21335","volume":"66","author":"LA Torre","year":"2016","unstructured":"Torre, L. A. et al. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females: Cancer Statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016. Ca. Cancer J. Clin. 66, 182\u2013202 (2016).","journal-title":"Ca. Cancer J. Clin."},{"key":"27889_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3322\/caac.21555","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis, C. E., Miller, K. D., Goding Sauer, A., Jemal, A. & Siegel, R. L. Cancer statistics for African Americans, 2019. Ca. Cancer J. Clin. 69, 211\u2013233 (2019).","journal-title":"Ca. Cancer J. Clin."},{"key":"27889_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ijc.2910040113","volume":"4","author":"PJ Cook","year":"1969","unstructured":"Cook, P. J., Doll, R. & Fellingham, S. A. A mathematical model for the age distribution of cancer in man. Int. J. Cancer 4, 93\u2013112 (1969).","journal-title":"Int. J. Cancer"},{"key":"27889_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrc3497","volume":"13","author":"JP de Magalh\u00e3es","year":"2013","unstructured":"de Magalh\u00e3es, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357\u2013365 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"27889_CR14","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/cncr.26376","volume":"118","author":"C Harding","year":"2012","unstructured":"Harding, C., Pompei, F. & Wilson, R. Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer 118, 1371\u20131386 (2012).","journal-title":"Cancer"},{"key":"27889_CR15","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White, M. C. et al. Age and Cancer Risk. Am. J. Prev. Med. 46, S7\u2013S15 (2014).","journal-title":"Am. J. Prev. Med."},{"key":"27889_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/35041694","volume":"408","author":"RA DePinho","year":"2000","unstructured":"DePinho, R. A. The age of cancer. Nature 408, 248 (2000).","journal-title":"Nature"},{"key":"27889_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1954.1","volume":"8","author":"P Armitage","year":"1954","unstructured":"Armitage, P. & Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1\u201312 (1954).","journal-title":"Br. J. Cancer"},{"key":"27889_CR18","first-page":"5","volume":"1","author":"WB Ershler","year":"2003","unstructured":"Ershler, W. B. Cancer: a disease of the elderly. J. Support. Oncol. 1, 5\u201310 (2003).","journal-title":"J. Support. Oncol."},{"key":"27889_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.14336\/AD.2017.0103","volume":"8","author":"JR Aunan","year":"2017","unstructured":"Aunan, J. R., Cho, W. C. & S\u00f8reide, K. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis. 8, 628 (2017).","journal-title":"Aging Dis."},{"key":"27889_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher, E. et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 18, 719\u2013731 (2017).","journal-title":"Lancet Oncol."},{"key":"27889_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2611","volume":"45","author":"The St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project.","year":"2013","unstructured":"The St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat. Genet. 45, 602\u2013612 (2013).","journal-title":"Nat. Genet."},{"key":"27889_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"The St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project.","year":"2014","unstructured":"The St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444\u2013450 (2014).","journal-title":"Nat. Genet."},{"key":"27889_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S1470-2045(16)00162-5","volume":"17","author":"A Trama","year":"2016","unstructured":"Trama, A. et al. Survival of European adolescents and young adults diagnosed with cancer in 2000\u201307: population-based data from EUROCARE-5. Lancet Oncol. 17, 896\u2013906 (2016).","journal-title":"Lancet Oncol."},{"key":"27889_CR24","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders, C. K. et al. Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression. J. Clin. Oncol. 26, 3324\u20133330 (2008).","journal-title":"J. Clin. Oncol."},{"key":"27889_CR25","first-page":"206","volume":"24","author":"B Tingstedt","year":"2011","unstructured":"Tingstedt, B., Weitk\u00e4mper, C. & Andersson, R. Early onset pancreatic cancer: a controlled trial. Ann. Gastroenterol. 24, 206\u2013212 (2011).","journal-title":"Ann. Gastroenterol."},{"key":"27889_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pan.2015.01.013","volume":"15","author":"M Piciucchi","year":"2015","unstructured":"Piciucchi, M. et al. Early onset pancreatic cancer: Risk factors, presentation and outcome. Pancreatology 15, 151\u2013155 (2015).","journal-title":"Pancreatology"},{"key":"27889_CR27","first-page":"62","volume":"6","author":"M Katz","year":"2013","unstructured":"Katz, M. et al. The Effect of Race\/Ethnicity on the Age of Colon Cancer Diagnosis. J. Health Disparities Res. Pract. 6, 62\u201369 (2013).","journal-title":"J. Health Disparities Res. Pract."},{"key":"27889_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/cncr.29871","volume":"122","author":"JV Tricoli","year":"2016","unstructured":"Tricoli, J. V. et al. Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast Cancer, melanoma, Sarcoma: Biology of AYA Cancers. Cancer 122, 1017\u20131028 (2016).","journal-title":"Cancer"},{"key":"27889_CR29","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/cncr.31994","volume":"125","author":"AN Willauer","year":"2019","unstructured":"Willauer, A. N. et al. Clinical and molecular characterization of early\u2010onset colorectal cancer. Cancer 125, 2002\u20132010 (2019).","journal-title":"Cancer"},{"key":"27889_CR30","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-19-0899","volume":"25","author":"CH Lieu","year":"2019","unstructured":"Lieu, C. H. et al. Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Clin. Cancer Res. 25, 5852\u20135858 (2019).","journal-title":"Clin. Cancer Res."},{"key":"27889_CR31","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D. W. et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science 321, 1807\u20131812 (2008).","journal-title":"Science"},{"key":"27889_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","volume":"7","author":"GR Williams","year":"2016","unstructured":"Williams, G. R. et al. Comorbidity in older adults with cancer. J. Geriatr. Oncol. 7, 249\u2013257 (2016).","journal-title":"J. Geriatr. Oncol."},{"key":"27889_CR33","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/bjc.2012.46","volume":"106","author":"TL J\u00f8rgensen","year":"2012","unstructured":"J\u00f8rgensen, T. L., Hallas, J., Friis, S. & Herrstedt, J. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br. J. Cancer 106, 1353\u20131360 (2012).","journal-title":"Br. J. Cancer"},{"key":"27889_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.suronc.2009.11.008","volume":"19","author":"L Balducci","year":"2010","unstructured":"Balducci, L., Colloca, G., Cesari, M. & Gambassi, G. Assessment and treatment of elderly patients with cancer. Surg. Oncol. 19, 117\u2013123 (2010).","journal-title":"Surg. Oncol."},{"key":"27889_CR35","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1002\/cncr.23939","volume":"113","author":"B Given","year":"2008","unstructured":"Given, B. & Given, C. W. Older adults and cancer treatment. Cancer 113, 3505\u20133511 (2008).","journal-title":"Cancer"},{"key":"27889_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semradonc.2012.05.002","volume":"22","author":"RC Chen","year":"2012","unstructured":"Chen, R. C., Royce, T. J., Extermann, M. & Reeve, B. B. Impact of Age and Comorbidity on Treatment and Outcomes in Elderly Cancer Patients. Semin. Radiat. Oncol. 22, 265\u2013271 (2012).","journal-title":"Semin. Radiat. Oncol."},{"key":"27889_CR37","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/1055-9965.EPI-13-0143","volume":"22","author":"AA Andaya","year":"2013","unstructured":"Andaya, A. A. et al. Race and Colon Cancer Survival in an Equal-Access Health Care System. Cancer Epidemiol. Biomark. Prev. 22, 1030\u20131036 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"27889_CR38","doi-asserted-by":"publisher","first-page":"24627","DOI":"10.18632\/oncotarget.5685","volume":"6","author":"B Milholland","year":"2015","unstructured":"Milholland, B., Auton, A., Suh, Y. & Vijg, J. Age-related somatic mutations in the cancer genome. Oncotarget 6, 24627\u201324635 (2015).","journal-title":"Oncotarget"},{"key":"27889_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ijrobp.2017.01.002","volume":"98","author":"DR Wahl","year":"2017","unstructured":"Wahl, D. R. et al. Pan-Cancer Analysis of Genomic Sequencing Among the Elderly. Int. J. Radiat. Oncol. 98, 726\u2013732 (2017).","journal-title":"Int. J. Radiat. Oncol."},{"key":"27889_CR40","unstructured":"Chalmers, Z. R. et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 9, 34 (2017)."},{"key":"27889_CR41","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911\u2013917 (2018).","journal-title":"Science"},{"key":"27889_CR42","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena, I. et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880\u2013886 (2015).","journal-title":"Science"},{"key":"27889_CR43","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1672-7","volume":"574","author":"H Lee-Six","year":"2019","unstructured":"Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532\u2013537 (2019).","journal-title":"Nature"},{"key":"27889_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312\u2013317 (2019).","journal-title":"Nature"},{"key":"27889_CR45","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","volume":"24","author":"K Suda","year":"2018","unstructured":"Suda, K. et al. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium. Cell Rep. 24, 1777\u20131789 (2018).","journal-title":"Cell Rep."},{"key":"27889_CR46","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"27889_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","volume":"150","author":"JS Welch","year":"2012","unstructured":"Welch, J. S. et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia. Cell 150, 264\u2013278 (2012).","journal-title":"Cell"},{"key":"27889_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molonc.2014.07.019","volume":"9","author":"HKM Vollan","year":"2015","unstructured":"Vollan, H. K. M. et al. A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer. Mol. Oncol. 9, 115\u2013127 (2015).","journal-title":"Mol. Oncol."},{"key":"27889_CR49","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S1470-2045(14)71021-6","volume":"15","author":"E Lalonde","year":"2014","unstructured":"Lalonde, E. et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. Lancet Oncol. 15, 1521\u20131532 (2014).","journal-title":"Lancet Oncol."},{"key":"27889_CR50","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1073\/pnas.1411446111","volume":"111","author":"H Hieronymus","year":"2014","unstructured":"Hieronymus, H. et al. Copy number alteration burden predicts prostate cancer relapse. Proc. Natl Acad. Sci. U.S.A. 111, 11139\u201311144 (2014).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"27889_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"27889_CR52","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51, 202\u2013206 (2019).","journal-title":"Nat. Genet."},{"key":"27889_CR53","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-18-0362","volume":"78","author":"CH Li","year":"2018","unstructured":"Li, C. H., Haider, S., Shiah, Y.-J., Thai, K. & Boutros, P. C. Sex Differences in Cancer Driver Genes and Biomarkers. Cancer Res. 78, 5527 (2018).","journal-title":"Cancer Res."},{"key":"27889_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17359-2","volume":"11","author":"PCAWG Tumour Subtypes and Clinical Translation.","year":"2020","unstructured":"PCAWG Tumour Subtypes and Clinical Translation. et al. Sex differences in oncogenic mutational processes. Nat. Commun. 11, 4330 (2020).","journal-title":"Nat. Commun."},{"key":"27889_CR55","unstructured":"PCAWG Evolution & Heterogeneity Working Group. et al. The evolutionary history of 2658 cancers. Nature 578, 122\u2013128 (2020)."},{"key":"27889_CR56","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cell.2018.03.029","volume":"173","author":"SMG Espiritu","year":"2018","unstructured":"Espiritu, S. M. G. et al. The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression. Cell 173, 1003\u20131013 (2018). e15.","journal-title":"Cell"},{"key":"27889_CR57","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau, D. A. et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia. Cell 152, 714\u2013726 (2013).","journal-title":"Cell"},{"key":"27889_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395\u2013399 (2012).","journal-title":"Nature"},{"key":"27889_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lungcan.2007.11.013","volume":"61","author":"K Asomaning","year":"2008","unstructured":"Asomaning, K. et al. Second hand smoke, age of exposure and lung cancer risk. Lung Cancer 61, 13\u201320 (2008).","journal-title":"Lung Cancer"},{"key":"27889_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"27889_CR61","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1126\/science.aag0299","volume":"354","author":"LB Alexandrov","year":"2016","unstructured":"Alexandrov, L. B. et al. Mutational signatures associated with tobacco smoking in human cancer. Science 354, 618\u2013622 (2016).","journal-title":"Science"},{"key":"27889_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"PCAWG Mutational Signatures Working Group.","year":"2020","unstructured":"PCAWG Mutational Signatures Working Group. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"27889_CR63","doi-asserted-by":"publisher","unstructured":"Alexandrov, L. et al. The Repertoire of Mutational Signatures in Human Cancer. (2018) https:\/\/doi.org\/10.1101\/322859.","DOI":"10.1101\/322859"},{"key":"27889_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"27889_CR65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium.","year":"2020","unstructured":"The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"27889_CR66","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"27889_CR67","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"PCAWG Drivers and Functional Interpretation Working Group.","year":"2020","unstructured":"PCAWG Drivers and Functional Interpretation Working Group. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"27889_CR68","doi-asserted-by":"publisher","first-page":"e1005333","DOI":"10.1371\/journal.pgen.1005333","volume":"11","author":"JB Stewart","year":"2015","unstructured":"Stewart, J. B. et al. Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers. PLOS Genet. 11, e1005333 (2015).","journal-title":"PLOS Genet."},{"key":"27889_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00377-y","volume":"8","author":"JF Hopkins","year":"2017","unstructured":"Hopkins, J. F. et al. Mitochondrial mutations drive prostate cancer aggression. Nat. Commun. 8, 656 (2017).","journal-title":"Nat. Commun."},{"key":"27889_CR70","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10549-009-0397-y","volume":"119","author":"C Ye","year":"2010","unstructured":"Ye, C. et al. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res. Treat. 119, 431\u2013436 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"27889_CR71","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.neurobiolaging.2013.11.027","volume":"35","author":"S Nugent","year":"2014","unstructured":"Nugent, S. et al. Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol. Aging 35, 1386\u20131395 (2014).","journal-title":"Neurobiol. Aging"},{"key":"27889_CR72","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1200\/JCO.2017.72.6737","volume":"35","author":"MJ van den Bent","year":"2017","unstructured":"van den Bent, M. J., Smits, M., Kros, J. M. & Chang, S. M. Diffuse Infiltrating Oligodendroglioma and Astrocytoma. J. Clin. Oncol. 35, 2394\u20132401 (2017).","journal-title":"J. Clin. Oncol."},{"key":"27889_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22560-y","volume":"12","author":"K Chatsirisupachai","year":"2021","unstructured":"Chatsirisupachai, K., Lesluyes, T., Paraoan, L., Van Loo, P. & de Magalh\u00e3es, J. P. An integrative analysis of the age-associated multi-omic landscape across cancers. Nat. Commun. 12, 2345 (2021).","journal-title":"Nat. Commun."},{"key":"27889_CR74","doi-asserted-by":"publisher","first-page":"a025130","DOI":"10.1101\/cshperspect.a025130","volume":"5","author":"S Maynard","year":"2015","unstructured":"Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L. & Bohr, V. A. DNA Damage, DNA Repair, Aging, and Neurodegeneration. Cold Spring Harb. Perspect. Med. 5, a025130 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"27889_CR75","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMra0804615","volume":"361","author":"JHJ Hoeijmakers","year":"2009","unstructured":"Hoeijmakers, J. H. J. DNA Damage. Aging, Cancer N. Engl. J. Med. 361, 1475\u20131485 (2009).","journal-title":"Aging, Cancer N. Engl. J. Med."},{"key":"27889_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrc.2015.1","volume":"16","author":"LC Fern\u00e1ndez","year":"2016","unstructured":"Fern\u00e1ndez, L. C., Torres, M. & Real, F. X. Somatic mosaicism: on the road to cancer. Nat. Rev. Cancer 16, 43\u201355 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"27889_CR77","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.aaf9011","volume":"355","author":"C Tomasetti","year":"2017","unstructured":"Tomasetti, C., Li, L. & Vogelstein, B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355, 1330\u20131334 (2017).","journal-title":"Science"},{"key":"27889_CR78","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.trecan.2017.02.002","volume":"3","author":"BC \u00d6zdemir","year":"2017","unstructured":"\u00d6zdemir, B. C. & Dotto, G.-P. Racial differences in cancer susceptibility and survival: more than the color of the skin? Trends Cancer 3, 181\u2013197 (2017).","journal-title":"Trends Cancer"},{"key":"27889_CR79","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.coi.2011.01.002","volume":"23","author":"DW Cramer","year":"2011","unstructured":"Cramer, D. W. & Finn, O. J. Epidemiologic perspective on immune-surveillance in cancer. Curr. Opin. Immunol. 23, 265\u2013271 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"27889_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40471-017-0096-x","volume":"4","author":"AD Vick","year":"2017","unstructured":"Vick, A. D. & Burris, H. H. Epigenetics and Health Disparities. Curr. Epidemiol. Rep. 4, 31\u201337 (2017).","journal-title":"Curr. Epidemiol. Rep."},{"key":"27889_CR81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"K Huang","year":"2018","unstructured":"Huang, K. et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell 173, 355\u2013370 (2018). e14.","journal-title":"Cell"},{"key":"27889_CR82","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018."},{"key":"27889_CR83","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A. & Wargo, J. A. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell 33, 570\u2013580 (2018).","journal-title":"Cancer Cell"},{"key":"27889_CR84","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/cncr.20408","volume":"101","author":"DG Bostwick","year":"2004","unstructured":"Bostwick, D. G. et al. Human prostate cancer risk factors. Cancer 101, 2371\u20132490 (2004).","journal-title":"Cancer"},{"key":"27889_CR85","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/carcin\/bgp252","volume":"31","author":"P Irigaray","year":"2010","unstructured":"Irigaray, P. & Belpomme, D. Basic properties and molecular mechanisms of exogenous chemical carcinogens. Carcinogenesis 31, 135\u2013148 (2010).","journal-title":"Carcinogenesis"},{"key":"27889_CR86","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","volume":"22","author":"L Talarico","year":"2004","unstructured":"Talarico, L., Chen, G. & Pazdur, R. Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug Administration. J. Clin. Oncol. 22, 4626\u20134631 (2004).","journal-title":"J. Clin. Oncol."},{"key":"27889_CR87","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/bcp.13876","volume":"85","author":"R Ruiter","year":"2019","unstructured":"Ruiter, R., Burggraaf, J. & Rissmann, R. Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database. Br. J. Clin. Pharmacol. 85, 838\u2013844 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"27889_CR88","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2020.04.012","volume":"37","author":"J Carrot-Zhang","year":"2020","unstructured":"Carrot-Zhang, J. et al. Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer. Cancer Cell 37, 639\u2013654 (2020). e6.","journal-title":"Cancer Cell"},{"key":"27889_CR89","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/biomet\/87.4.954","volume":"87","author":"I-K Yeo","year":"2000","unstructured":"Yeo, I.-K. & Johnson, R. A. A New Family of Power Transformations to Improve Normality or Symmetry. Biometrika 87, 954\u2013959 (2000).","journal-title":"Biometrika"},{"key":"27889_CR90","unstructured":"P\u2019ng, C. et al. BPG: Seamless, automated and interactive visualization of scientific data. BMC Bioinform. 20, 42 (2019)."},{"key":"27889_CR91","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"The AACR Project GENIE Consortium.","year":"2017","unstructured":"The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Disco. 7, 818\u2013831 (2017).","journal-title":"Cancer Disco."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27889-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:42:15Z","timestamp":1669286535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27889-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27889"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27889-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.07.192237","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}